NO20004142L - Ftalimidoarylpiperaziner som <alfa> 1A reseptorantagonister anvendelige ved behandling av benign prostatahyperplasi - Google Patents

Ftalimidoarylpiperaziner som <alfa> 1A reseptorantagonister anvendelige ved behandling av benign prostatahyperplasi

Info

Publication number
NO20004142L
NO20004142L NO20004142A NO20004142A NO20004142L NO 20004142 L NO20004142 L NO 20004142L NO 20004142 A NO20004142 A NO 20004142A NO 20004142 A NO20004142 A NO 20004142A NO 20004142 L NO20004142 L NO 20004142L
Authority
NO
Norway
Prior art keywords
phthalimidoarylpiperazines
alfa
treatment
receptor antagonists
benign prostate
Prior art date
Application number
NO20004142A
Other languages
English (en)
Other versions
NO317104B1 (no
NO20004142D0 (no
Inventor
Gee-Hong Kuo
William V Murray
Catherine P Prouty
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Publication of NO20004142D0 publication Critical patent/NO20004142D0/no
Publication of NO20004142L publication Critical patent/NO20004142L/no
Publication of NO317104B1 publication Critical patent/NO317104B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
NO20004142A 1998-02-20 2000-08-18 Ftalimidoarylpiperaziner som <alfa> 1A reseptorantagonister anvendelige ved behandling av benign prostata hyperplasi, og farmasoytisk sammensetning innbefattende samme NO317104B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7551098P 1998-02-20 1998-02-20
PCT/US1999/003694 WO1999042445A1 (en) 1998-02-20 1999-02-19 Phtalimido arylpiperazines as alpha 1a receptor antagonists useful in the treatment of benign prostatic hyperplasia

Publications (3)

Publication Number Publication Date
NO20004142D0 NO20004142D0 (no) 2000-08-18
NO20004142L true NO20004142L (no) 2000-10-19
NO317104B1 NO317104B1 (no) 2004-08-09

Family

ID=22126243

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20004142A NO317104B1 (no) 1998-02-20 2000-08-18 Ftalimidoarylpiperaziner som <alfa> 1A reseptorantagonister anvendelige ved behandling av benign prostata hyperplasi, og farmasoytisk sammensetning innbefattende samme

Country Status (21)

Country Link
US (2) US20020077476A1 (no)
EP (1) EP1056720B1 (no)
JP (1) JP2002503722A (no)
KR (1) KR100608473B1 (no)
CN (1) CN1172911C (no)
AR (1) AR015521A1 (no)
AT (1) ATE280156T1 (no)
AU (1) AU766411B2 (no)
BR (1) BR9908122A (no)
DE (1) DE69921300T2 (no)
ES (1) ES2233023T3 (no)
HK (1) HK1031872A1 (no)
HU (1) HUP0100704A3 (no)
IL (2) IL137953A0 (no)
NO (1) NO317104B1 (no)
NZ (1) NZ506461A (no)
PL (1) PL194649B1 (no)
PT (1) PT1056720E (no)
TR (1) TR200003224T2 (no)
WO (1) WO1999042445A1 (no)
ZA (1) ZA991319B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20010164A1 (it) * 2001-01-30 2002-07-30 Recordati Chem Pharm Alfa 1 antagonisti selettivi a + d
CN103387531A (zh) * 2012-05-10 2013-11-13 广州医学院 酰胺类芳基哌嗪衍生物及其制备方法和在抗良性前列腺增生中的应用
HUP1400294A2 (hu) 2014-06-13 2015-12-28 Skillpharm Kft Clopidogrel új alkalmazása
CN106966940B (zh) * 2015-07-30 2019-03-19 新发药业有限公司 一种西他列汀磷酸盐中间体n-芳甲基-2s-氰基甲基吖啶的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1382742A (en) 1972-09-19 1975-02-05 Labaz Benzofuran derivatives and process for preparing the same
CH585693A5 (no) 1974-02-08 1977-03-15 Ciba Geigy Ag
HU177702B (en) 1977-10-24 1981-12-28 Noevenyvedelmi Kutato Intezet Plant growth regulator and process for preparing the active materials
PT82077B (fr) * 1985-02-26 1987-09-25 Sanofi Sa Procede pour l'obtention des derives aminoalcools peptidiques inhibiteurs de la renine et des proteases acides
FR2678271B1 (fr) * 1991-06-27 1995-01-13 Synthelabo Derives de pyrimidine-4-carboxamide, leur preparation et leur application en therapeutique.
US5428037A (en) * 1993-04-09 1995-06-27 Syntex Pharmaceuticals, Ltd. Heterocyclic derivatives in the treatment of Ischaemia and related diseases
HUP0100048A3 (en) * 1997-05-12 2002-12-28 Ortho Mcneil Pharm Inc Arylsubstituted piperazine-derivatives, useful in the treatement of benign prostatic hyperlasia use of them for producing pharmaceutical compositions and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
KR20010041118A (ko) 2001-05-15
KR100608473B1 (ko) 2006-08-09
PL342357A1 (en) 2001-06-04
ATE280156T1 (de) 2004-11-15
US6780994B2 (en) 2004-08-24
ES2233023T3 (es) 2005-06-01
PT1056720E (pt) 2005-02-28
AU766411B2 (en) 2003-10-16
NZ506461A (en) 2003-08-29
CN1172911C (zh) 2004-10-27
BR9908122A (pt) 2001-11-13
HUP0100704A2 (hu) 2001-10-28
IL137953A0 (en) 2001-10-31
NO317104B1 (no) 2004-08-09
IL137953A (en) 2006-12-31
EP1056720B1 (en) 2004-10-20
WO1999042445A1 (en) 1999-08-26
JP2002503722A (ja) 2002-02-05
HK1031872A1 (en) 2001-06-29
US20030088099A1 (en) 2003-05-08
CN1291185A (zh) 2001-04-11
AU2776599A (en) 1999-09-06
US20020077476A1 (en) 2002-06-20
HUP0100704A3 (en) 2002-10-28
DE69921300T2 (de) 2006-03-09
NO20004142D0 (no) 2000-08-18
TR200003224T2 (tr) 2001-03-21
AR015521A1 (es) 2001-05-02
EP1056720A1 (en) 2000-12-06
ZA991319B (en) 2000-11-20
PL194649B1 (pl) 2007-06-29
DE69921300D1 (de) 2004-11-25

Similar Documents

Publication Publication Date Title
DE60023982D1 (de) System zur Behandlung von benigner Prostatahyperplasie
NO993396D0 (no) Kinolin- ig kinolinforbindelser nyttige i terapi, spesielt i behandlingen av benign prostatisk hyperplasi
ID29021A (id) Komposisi galantamina pelepasan terkontrol
DE59902470D1 (de) Neue 2-heterocyclisch substituierte dihydropyrimidine
HUP9903732A3 (en) Use of cgmp elevators for the preparation of pharmaceutical compositions treating benign prostatic hyperplasia
ID27007A (id) Komposisi pencucian perorangan
NO20012638L (no) Blandinger og fremgangsmåter for å kontrollere avsetning av vann-ulöselige ingredienser
MXPA03009720A (es) USO DE ANTAGONISTAS DEL RECEPTOR DE NK-1 PARA TRATAMIENTO O PREVENCIoN DE HIPERPLASIA PROSTATICA BENIGNA.
DE69939166D1 (de) Wasserenthärtungs- und waschmittelzusammensetzungen
PT1022396E (pt) Combinacao de duche
NO995518D0 (no) Arylsubstituerte piperaziner brukbare ved behandling av benign prostatisk hyperplasi
IS5502A (is) Samtengd efnasambönd nytsamleg við meðhöndlun á krabbameini í blöðruhálskirtli
IL137954A0 (en) Novel substituted pyridino arylpiperazines useful in the treatment of benign prostatic hyperplasia
NO20004142L (no) Ftalimidoarylpiperaziner som &lt;alfa&gt; 1A reseptorantagonister anvendelige ved behandling av benign prostatahyperplasi
DE69930869D1 (de) Kosmetische schicht
IS6052A (is) Resorsinól efnasamsetning
FR2859910B1 (fr) Utilisation du 1-alpha-fluoro-25-hydroxy-16,23e-diene-26,27- bishomo-20-epi-cholecalciferol pour le traitement de l&#39;hyperplasie benigne de la prostate
DE19983264B8 (de) Spektrumwassergenerator
NO20022142L (no) Anvendelse av dopamin-D3 reseptor agonister for behandling av saltavhengig hypertensjon
BR9608912A (pt) Agonistas de meletonina para o tratamento de hiperplasia prostática benigna
DK1056720T3 (da) Phtalimido-arylpiperaziner som alfa-1A-receptorantagonister, der er nyttige til behandling af godartet prostatahyperplasi
AU1036701A (en) Use of acetyl salicilyc acid for the treatment of benign prostate hyperplasia
NO20005856D0 (no) Anvendelse av 1,1-diokso-perhydro-1,2,4-tiadiaziner
GB9810895D0 (en) Combination therapy for the treatment of benign prostatic hyperplasia
GB9602903D0 (en) Conjugates useful in the treatment of benign prostatic hyperplasia

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees